Clinical trial
Ketoconazole Plus Docetaxel to Treat Prostate Cancer
NCT00032825 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00032825 |
|---|---|
| Title | Ketoconazole Plus Docetaxel to Treat Prostate Cancer |
| Official title | A Phase I Trial of High Dose Ketoconazole Plus Weekly Docetaxel in Metastatic Androgen Independent Prostate Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms |
| Intervention type | Drug |
| Interventions | Ketaconazole, Docetaxel |
| Enrollment | 674 |
| Start date | Mar 19, 2002 |
| Completion | Jun 13, 2011 |
| First posted | Apr 4, 2002 |
| Last update posted | Nov 21, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: